Lorence H. Kim - 18 Jun 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: Director
Issuer ticker: RVMD
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jun 2026, 17:57:09 UTC
Prior SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim

Key filing fact

Lorence H. Kim filed Form 4 for Revolution Medicines, Inc. (RVMD) on 23 Jun 2026.

Key facts

This page summarizes Lorence H. Kim's Form 4 filing for Revolution Medicines, Inc. (RVMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2026, 17:57.

Change

Previous filing in this sequence was filed on 09 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643746 Primary reporting owner

Kim Lorence H.

Relationship: Director
Address: C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DR, REDWOOD CITY
Signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim
Signature date: 23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Award

Transaction value
Shares: +1,191
Change %: +1.6%
Price: $0.000000^*
Shares after: 74,281
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +3,127
Change %
Price: $0.000000^*
Shares after: 3,127
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,127
Exercise price: $162.99
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 1,191 restricted stock units.

Footnote F2

Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.